The Mechanism of Pyroptosis and Its Application Prospect in Diabetic Wound Healing

References

• Louiselle AE, Niemiec SM, Zgheib C, Liechty KW. Macrophage polarization and diabetic wound healing. Translational Res. 2021;236:109–116. doi:10.1016/j.trsl.2021.05.006
   PubMed Web of Science ®Google Scholar
• Boniakowski AE, Kimball AS, Jacobs BN, Kunkel SL, Gallagher KA. Macrophage-Mediated Inflammation in Normal and Diabetic Wound Healing. J Immunol. 2017;199(1):17–24. doi:10.4049/jimmunol.1700223
   PubMed Web of Science ®Google Scholar
• Akkus G, Sert M. Diabetic foot ulcers: a devastating complication of diabetes mellitus continues non-stop in spite of new medical treatment modalities. World j Diabetes. 2022;13(12):1106–1121. doi:10.4239/wjd.v13.i12.1106
   PubMed Web of Science ®Google Scholar
• Gosak L, Svensek A, Lorber M, Stiglic G. Artificial Intelligence Based Prediction of Diabetic Foot Risk in Patients with Diabetes: a Literature Review. Appl Sci. 2023;13(5):2823. doi:10.3390/app13052823
   Google Scholar
• Hingorani A, LaMuraglia GM, Henke P, et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine. J Vascular Surg. 2016;63(2 Suppl):3s–21s. doi:10.1016/j.jvs.2015.10.003
   PubMed Web of Science ®Google Scholar
• Hicks CW, Selvarajah S, Mathioudakis N, et al. Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs. Ann Vasc Surg. 2016;33:149–158. doi:10.1016/j.avsg.2015.11.025
   PubMed Web of Science ®Google Scholar
• Prompers L, Schaper N, Apelqvist J, et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia. 2008;51(5):747–755. doi:10.1007/s00125-008-0940-0
   PubMed Web of Science ®Google Scholar
• Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 2013;62(1):194–204. doi:10.2337/db12-0420
   PubMed Web of Science ®Google Scholar
• Bitto A, Altavilla D, Pizzino G, et al. Inhibition of inflammasome activation improves the impaired pattern of healing in genetically diabetic mice. Br J Pharmacol. 2014;171(9):2300–2307. doi:10.1111/bph.12557
   PubMed Web of Science ®Google Scholar
• Ding S, Xu S, Ma Y, Liu G. Modulatory Mechanisms of the NLRP3 Inflammasomes in Diabetes. Biomolecules. 2019;9(12).
   Web of Science ®Google Scholar
• Mirza RE, Fang MM, Weinheimer-Haus EM, Ennis WJ, Koh TJ. Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice. Diabetes. 2014;63(3):1103–1114. doi:10.2337/db13-0927
   PubMed Web of Science ®Google Scholar
• Feng H, Gu J, Gou F, et al. High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells. J Diabetes Res. 2016;2016:6973175. doi:10.1155/2016/6973175
   PubMed Web of Science ®Google Scholar
• Qiu YY, Tang LQ. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacol Res. 2016;114:251–264. doi:10.1016/j.phrs.2016.11.004
   PubMed Web of Science ®Google Scholar
• Qiu Z, He Y, Ming H, Lei S. Lipopolysaccharide (LPS) Aggravates High Glucose- and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes. J Diabetes Res. 2019;2019:8151836. doi:10.1155/2019/8151836
   PubMed Web of Science ®Google Scholar
• Liu D, Yang P, Gao M, et al. NLRP3 activation induced by neutrophil extracellular traps sustains inflammatory response in the diabetic wound. Clin Sci. 2019;133(4):565–582. doi:10.1042/cs20180600
   PubMed Web of Science ®Google Scholar
• Huang C, Ogawa R. Role of Inflammasomes in Keloids and Hypertrophic Scars-Lessons Learned from Chronic Diabetic Wounds and Skin Fibrosis. Biomolecules. 2022;23(12).
   Google Scholar
• Brokatzky D, Mostowy S. Pyroptosis in host defence against bacterial infection. Dis Models Mech. 2022;15(7). doi:10.1242/dmm.049414
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang B, Li S, Yang S. Pyroptosis, and its Role in Central Nervous System Disease. J Mol Biol. 2022;434(4):167379. doi:10.1016/j.jmb.2021.167379
   PubMed Web of Science ®Google Scholar
• Hu X, Chen H, Xu H, et al. Role of Pyroptosis in Traumatic Brain and Spinal Cord Injuries. Int J Bio Sci. 2020;16(12):2042–2050. doi:10.7150/ijbs.45467
   Google Scholar
• Zhaolin Z, Guohua L, Shiyuan W, Zuo W. Role of pyroptosis in cardiovascular disease. Mar. 2019;52(2):e12563. doi:10.1111/cpr.12563
   Google Scholar
• Rao Z, Zhu Y, Yang P, et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022;12(9):4310–4329. doi:10.7150/thno.71086
   PubMed Web of Science ®Google Scholar
• Li X, Xiao GY, Guo T, Song YJ, Li QM. Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications. Front Endocrinol. 2022;13:986565. doi:10.3389/fendo.2022.986565
   PubMed Web of Science ®Google Scholar
• Yang S, Feng Y, Chen L, et al. Disulfiram accelerates diabetic foot ulcer healing by blocking NET formation via suppressing the NLRP3/Caspase-1/GSDMD pathway. Translational res. 2023;254:115–127. doi:10.1016/j.trsl.2022.10.008
   PubMed Web of Science ®Google Scholar
• Yang H, Zhang Y, Du Z, Wu T, Yang C. Hair follicle mesenchymal stem cell exosomal lncRNA H19 inhibited NLRP3 pyroptosis to promote diabetic mouse skin wound healing. Aging. 2023;15(3):791–809. doi:10.18632/aging.204513
   PubMedGoogle Scholar
• Verma V, Dhanda RS, Møller NF, Yadav M. Inflammasomes and Their Role in Innate Immunity of Sexually Transmitted Infections. Front Immunol. 2016;7:540. doi:10.3389/fimmu.2016.00540
   PubMed Web of Science ®Google Scholar
• Khare S, Luc N, Dorfleutner A, Stehlik C. Inflammasomes and their activation. Critical Rev Immunol. 2010;30(5):463–487. doi:10.1615/critrevimmunol.v30.i5.50
   PubMed Web of Science ®Google Scholar
• Rathinam VA, Fitzgerald KA. Inflammasome Complexes: emerging Mechanisms and Effector Functions. Cell. 2016;165(4):792–800. doi:10.1016/j.cell.2016.03.046
   PubMed Web of Science ®Google Scholar
• Fu J, Wu H. Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation. Ann Rev Immunol. 2023;41(1):301–316. doi:10.1146/annurev-immunol-081022-021207
   PubMedGoogle Scholar
• Shi J, Zhao Y, Wang K, et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 2015;526(7575):660–665. doi:10.1038/nature15514
   PubMed Web of Science ®Google Scholar
• Wang K, Sun Q, Zhong X, et al. Structural Mechanism for GSDMD Targeting by Autoprocessed Caspases in Pyroptosis. Cell. 2020;180(5):941–955.e20. doi:10.1016/j.cell.2020.02.002
   PubMed Web of Science ®Google Scholar
• Sun Q, Scott MJ. Caspase-1 as a multifunctional inflammatory mediator: noncytokine maturation roles. J Leukocyte Biol. 2016;100(5):961–967. doi:10.1189/jlb.3MR0516-224R
   PubMed Web of Science ®Google Scholar
• Liu X, Xia S. Channelling inflammation: gasdermins in physiology and disease. Nat Rev Drug Discovery. 2021;20(5):384–405. doi:10.1038/s41573-021-00154-z
   PubMed Web of Science ®Google Scholar
• Li H, Wang Z, Fang X, et al. Poroptosis: a form of cell death depending on plasma membrane nanopores formation. iScience. 2022;25(6):104481. doi:10.1016/j.isci.2022.104481
   PubMed Web of Science ®Google Scholar
• Shi J, Gao W, Shao F. Pyroptosis: gasdermin-Mediated Programmed Necrotic Cell Death. Trends Biochem Sci. 2017;42(4):245–254. doi:10.1016/j.tibs.2016.10.004
   PubMed Web of Science ®Google Scholar
• Xu Z, Chen ZM, Wu X, Zhang L, Cao Y, Zhou P. Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation. Front Immunol. 2020;11:609441. doi:10.3389/fimmu.2020.609441
   PubMed Web of Science ®Google Scholar
• Li Q, Shi N, Cai C, et al. The Role of Mitochondria in Pyroptosis. Front Cell Develop Biol. 2020;8:630771. doi:10.3389/fcell.2020.630771
   PubMedGoogle Scholar
• Wang Y, Shi P, Chen Q, et al. Mitochondrial ROS promote macrophage pyroptosis by inducing GSDMD oxidation. J Mol Cell Biol. 2019;11(12):1069–1082. doi:10.1093/jmcb/mjz020
   PubMed Web of Science ®Google Scholar
• De torre-minguela C, Gómez AI, Couillin I, Pelegrín P. Gasdermins mediate cellular release of mitochondrial DNA during pyroptosis and apoptosis. Biomolecules. 2021;35(8):e21757. doi:10.1096/fj.202100085R
   Google Scholar
• Alu A, Han X, Ma X, Wu M, Wei Y, Wei X. The role of lysosome in regulated necrosis. Acta pharmaceutica Sinica B. 2020;10(10):1880–1903. doi:10.1016/j.apsb.2020.07.003
   PubMed Web of Science ®Google Scholar
• Green JP, Yu S, Martín-Sánchez F, Pelegrin P, Lopez-Castejon G. Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming. Biomolecules. 2018;115(40):E9371–e9380. doi:10.1073/pnas.1812744115
   Google Scholar
• Loomis WP, Bergsbaken T. Monitoring Calcium Fluxes and Lysosome Exocytosis During Pyroptosis. Methods Mol Biol. 2023;2641:171–178. doi:10.1007/978-1-0716-3040-2_14
   PubMedGoogle Scholar
• Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 Inflammasome: an Overview of Mechanisms of Activation and Regulation. Int J Mol Sci. 2019;20(13):3328. doi:10.3390/ijms20133328
   PubMed Web of Science ®Google Scholar
• Pelegrin P, Surprenant A. The P2X(7) receptor-pannexin connection to dye uptake and IL-1beta release. Purinergic Signalling. 2009;5(2):129–137. doi:10.1007/s11302-009-9141-7
   PubMed Web of Science ®Google Scholar
• Dahl G. ATP release through pannexon channels. Philos Trans R Soc London. 2015;370(1672). doi:10.1098/rstb.2014.0191
   PubMed Web of Science ®Google Scholar
• Kayagaki N, Warming S, Lamkanfi M, et al. Non-canonical inflammasome activation targets caspase-11. Nature. 2011;479(7371):117–121. doi:10.1038/nature10558
   PubMed Web of Science ®Google Scholar
• Mazgaeen L, Gurung P. Recent Advances in Lipopolysaccharide Recognition Systems. Int J Mol Sci. 2020;21(2):379. doi:10.3390/ijms21020379
   PubMed Web of Science ®Google Scholar
• Yi YS. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses. Immunology. 2017;152(2):207–217. doi:10.1111/imm.12787
   PubMed Web of Science ®Google Scholar
• Burdette BE, Esparza AN, Zhu H, Wang S. Gasdermin D in pyroptosis. Acta pharmaceutica Sinica B. 2021;11(9):2768–2782. doi:10.1016/j.apsb.2021.02.006
   PubMed Web of Science ®Google Scholar
• Aglietti RA, Estevez A, Gupta A, et al. GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes. Proc Natl Acad Sci USA. 2016;113(28):7858–7863. doi:10.1073/pnas.1607769113
   PubMed Web of Science ®Google Scholar
• Yang D, He Y, Muñoz-Planillo R, Liu Q, Núñez G. Caspase-11 Requires the Pannexin-1 Channel and the Purinergic P2X7 Pore to Mediate Pyroptosis and Endotoxic Shock. Immunity. 2015;43(5):923–932. doi:10.1016/j.immuni.2015.10.009
   PubMed Web of Science ®Google Scholar
• Katsnelson MA, Rucker LG, Russo HM, Dubyak GR. K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling. J Iimmunol. 2015;194(8):3937–3952. doi:10.4049/jimmunol.1402658
   PubMed Web of Science ®Google Scholar
• Inoue S, Browne G, Melino G, Cohen GM. Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Differ 2009;16(7):1053–1061. doi:10.1038/cdd.2009.29
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547(7661):99–103. doi:10.1038/nature22393
   PubMed Web of Science ®Google Scholar
• Hou J, Zhao R, Xia W, et al. PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nature Cell Biol. 2020;22(10):1264–1275. doi:10.1038/s41556-020-0575-z
   PubMed Web of Science ®Google Scholar
• Zhang JY, Zhou B, Sun RY, et al. The metabolite α-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8. Cell Res. 2021;31(9):980–997. doi:10.1038/s41422-021-00506-9
   PubMed Web of Science ®Google Scholar
• van Daalen KR, Reijneveld JF, Bovenschen N. Modulation of Inflammation by Extracellular Granzyme A. Front Immunol. 2020;11:931. doi:10.3389/fimmu.2020.00931
   PubMed Web of Science ®Google Scholar
• Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Ann Rev Immunol. 2008;26(1):389–420. doi:10.1146/annurev.immunol.26.021607.090404
   PubMedGoogle Scholar
• Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity. Nature. 2020;579(7799):415–420. doi:10.1038/s41586-020-2071-9
   PubMed Web of Science ®Google Scholar
• Zhou Z, He H. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Biomolecules. 2020;368(6494). doi:10.1126/science.aaz7548
   Google Scholar
• Feng Z, Zang C, Zhang L, Yin S, Zhuang Q, Wang X. STING activation promotes inflammatory response and delays skin wound healing in diabetic mice. Biochem Biophys Res Commun. 2022;611:126–131. doi:10.1016/j.bbrc.2022.04.085
   PubMed Web of Science ®Google Scholar
• Balderas-Cordero D, Canales-Alvarez O, Sánchez-Sánchez R, Cabrera-Wrooman A, Canales-Martinez MM, Rodriguez-Monroy MA. Anti-Inflammatory and Histological Analysis of Skin Wound Healing through Topical Application of Mexican Propolis. Int J Mol Sci. 2023;24(14). doi:10.3390/ijms241411831
   PubMed Web of Science ®Google Scholar
• Mori R, Tanaka K, de Kerckhove M, et al. Reduced FOXO1 expression accelerates skin wound healing and attenuates scarring. Am J Pathol. 2014;184(9):2465–2479. doi:10.1016/j.ajpath.2014.05.012
   PubMed Web of Science ®Google Scholar
• Zhao P, Cai Z, Zhang X, Liu M, Xie F, Liu Z. Hydrogen Attenuates Inflammation by Inducing Early M2 Macrophage Polarization in Skin Wound Healing. Biomolecules. 2023;16(6).
   Google Scholar
• Yang P, Wang X. Topical insulin application accelerates diabetic wound healing by promoting anti-inflammatory macrophage polarization. Int J Med. 2020;133(19).
   Google Scholar
• Ketelut-Carneiro N, Fitzgerald KA. The Many Ways a Cell Can Die. J Mol Biol. 2022;434(4):167378. doi:10.1016/j.jmb.2021.167378
   PubMed Web of Science ®Google Scholar
• Ito H, Kanbe A, Sakai H, Seishima M. Activation of NLRP3 signalling accelerates skin wound healing. Exp dermatol. 2018;27(1):80–86. doi:10.1111/exd.13441
   PubMed Web of Science ®Google Scholar
• Dai J, Zhang X, Wang Y, Chen H, Chai Y. ROS-activated NLRP3 inflammasome initiates inflammation in delayed wound healing in diabetic rats. Int J Clin Exp Pathol. 2017;10(9):9902–9909.
   PubMed Web of Science ®Google Scholar
• Zhao R, Liang H, Clarke E, Jackson C, Xue M. Inflammation in Chronic Wounds. Int J Mol Sci. 2016;17(12):2085. doi:10.3390/ijms17122085
   PubMed Web of Science ®Google Scholar
• Ao X, Yan H, Huang M, et al. Lavender essential oil accelerates lipopolysaccharide-induced chronic wound healing by inhibiting caspase-11-mediated macrophage pyroptosis. Kaohsiung J Med Sci. 2023;39(5):511–521. doi:10.1002/kjm2.12654
   PubMed Web of Science ®Google Scholar
• Ou ZL, Wang J, Shi R, Deng J, Liu Y, Luo GX. Influence of reactive oxygen species responsive self-assembled nanomicelle loaded with pyroptosis inhibitor on full-thickness skin defects in diabetic rats. Zhonghua shao shang za zhi. 2023;39(1):35–44. doi:10.3760/cma.j.cn501225-20221109-00483
   Google Scholar
• Chen C, Wang Q, Li D, Qi Z, Chen Y, Wang S. MALAT1 participates in the role of platelet-rich plasma exosomes in promoting wound healing of diabetic foot ulcer. Int J Biol Macromol. 2023;238:124170. doi:10.1016/j.ijbiomac.2023.124170
   PubMed Web of Science ®Google Scholar
• He Y, Zeng MY, Yang D, Motro B, Núñez G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature. 2016;530(7590):354–357. doi:10.1038/nature16959
   PubMed Web of Science ®Google Scholar
• Sharif H, Wang L, Wang WL, et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019;570(7761):338–343. doi:10.1038/s41586-019-1295-z
   PubMed Web of Science ®Google Scholar
• Song Y, Yang L, Guo R, Lu N, Shi Y, Wang X. Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22. Biochem Biophys Res Commun. 2019;509(2):359–366. doi:10.1016/j.bbrc.2018.12.139
   PubMed Web of Science ®Google Scholar
• Wu A, Sun W, Mou F. lncRNA‑MALAT1 promotes high glucose‑induced H9C2 cardiomyocyte pyroptosis by downregulating miR‑141‑3p expression. Mol Med Rep. 2021;23(4).
   Web of Science ®Google Scholar
• Zuo Y, Chen L, He X, et al. Atorvastatin Regulates MALAT1/miR-200c/NRF2 Activity to Protect Against Podocyte Pyroptosis Induced by High Glucose. Diabetes Metabolic Syndrome Obesity. 2021;14:1631–1645. doi:10.2147/dmso.s298950
   PubMed Web of Science ®Google Scholar
• Boal-Carvalho I, Mazel-Sanchez B, Silva F, Garnier L, Yildiz S, Bonifacio JP. Influenza A viruses limit NLRP3-NEK7-complex formation and pyroptosis in human macrophages. EMBO Reports. 2020;21(12):e50421. doi:10.15252/embr.202050421
   PubMed Web of Science ®Google Scholar
• He WT, Wan H, Hu L, et al. Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion. Cell Res. 2015;25(12):1285–1298. doi:10.1038/cr.2015.139
   PubMed Web of Science ®Google Scholar
• Lara-Reyna S, Caseley EA. Inflammasome activation: from molecular mechanisms to autoinflammation. Clinical Translational immunol. 2022;11(7):e1404. doi:10.1002/cti2.1404
   PubMed Web of Science ®Google Scholar
• Yu ZW, Zhang J, Li X, Wang Y, Fu YH, Gao XY. A new research hot spot: the role of NLRP3 inflammasome activation, a key step in pyroptosis, in diabetes and diabetic complications. Life Sci. 2020;240:117138. doi:10.1016/j.lfs.2019.117138
   PubMed Web of Science ®Google Scholar
• Xu YF, Wu YX, Wang HM, Gao CH, Xu YY, Yan Y. Bone marrow-derived mesenchymal stem cell-conditioned medium ameliorates diabetic foot ulcers in rats. Clinics. 2023;78:100181. doi:10.1016/j.clinsp.2023.100181
   PubMed Web of Science ®Google Scholar
• Kambara H, Liu F, Zhang X, et al. Gasdermin D Exerts Anti-inflammatory Effects by Promoting Neutrophil Death. Cell Rep. 2018;22(11):2924–2936. doi:10.1016/j.celrep.2018.02.067
   PubMed Web of Science ®Google Scholar
• Karnam K, Sedmaki K, Sharma P, Venuganti VVK, Kulkarni OP. Selective inhibition of PKR by C16 accelerates diabetic wound healing by inhibiting NALP3 expression in mice. Feb. 2023;72(2):221–236. doi:10.1007/s00011-022-01667-y
   Google Scholar
• Weinheimer-Haus EM, Mirza RE, Koh TJ. Nod-like receptor protein-3 inflammasome plays an important role during early stages of wound healing. PLoS One. 2015;10(3):e0119106. doi:10.1371/journal.pone.0119106
   PubMed Web of Science ®Google Scholar
• Ding Y, Ding X. Relevance of NLRP3 Inflammasome-Related Pathways in the Pathology of Diabetic Wound Healing and Possible Therapeutic Targets. Oxidative Med Cell Longevity. 2022;2022:9687925. doi:10.1155/2022/9687925
   PubMed Web of Science ®Google Scholar
• Geng K, Ma X, Jiang Z, et al. Innate Immunity in Diabetic Wound Healing: focus on the Mastermind Hidden in Chronic Inflammatory. Front Pharmacol. 2021;12:653940. doi:10.3389/fphar.2021.653940
   PubMed Web of Science ®Google Scholar
• Li X, Xie X, Lian W, et al. Exosomes from adipose-derived stem cells overexpressing Nrf2 accelerate cutaneous wound healing by promoting vascularization in a diabetic foot ulcer rat model. Biomolecules. 2018;50(4):1–14. doi:10.1038/s12276-018-0058-5
   Google Scholar
• Zhang X, Dai J, Li L, Chen H. NLRP3 Inflammasome Expression and Signaling in Human Diabetic Wounds and in High Glucose Induced Macrophages. J Diabetes Res. 2017;2017:5281358. doi:10.1155/2017/5281358
   PubMed Web of Science ®Google Scholar
• Wan L, Bai X, Zhou Q, et al. The advanced glycation end-products (AGEs)/ROS/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration. Int J Bio Sci. 2022;18(2):809–825. doi:10.7150/ijbs.63219
   Google Scholar
• Lee MKS, Sreejit G, Nagareddy PR, Murphy AJ. Attack of the NETs! NETosis primes IL-1β-mediated inflammation in diabetic foot ulcers. Clin Sci. 2020;134(12):1399–1401. doi:10.1042/cs20200240
   Web of Science ®Google Scholar
• Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD. The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes. Curr Biol. 2007;17(13):1140–1145. doi:10.1016/j.cub.2007.05.074
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang S. NLRP3 Inflammasome and Inflammatory Diseases. Oxidative Med Cell Longevity. 2020;2020:4063562. doi:10.1155/2020/4063562
   PubMed Web of Science ®Google Scholar
• Luo Z. Targeting the NOD-Like Receptor Pyrin Domain Containing 3 Inflammasome to Improve Healing of Diabetic Wounds. Adv Wound Care. 2023;12(11):644–656. doi:10.1089/wound.2021.0148
   Web of Science ®Google Scholar
• González P, Lozano P. Hyperglycemia and Oxidative Stress: an Integral, Updated and Critical Overview of Their Metabolic Interconnections. Biomolecules. 2023;24(11).
   Google Scholar
• Lu J, Holmgren A. The thioredoxin antioxidant system. Free Radic Biol Med. 2014;66:75–87. doi:10.1016/j.freeradbiomed.2013.07.036
   PubMed Web of Science ®Google Scholar
• Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol. 2010;11(2):136–140. doi:10.1038/ni.1831
   PubMed Web of Science ®Google Scholar
• Jiang L, Fei D, Gong R, et al. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury. Inflammation Res. 2016;65(11):905–915. doi:10.1007/s00011-016-0973-7
   PubMed Web of Science ®Google Scholar
• Zhan Y, Xu D, Tian Y, et al. Novel role of macrophage TXNIP-mediated CYLD-NRF2-OASL1 axis in stress-induced liver inflammation and cell death. JHEP Rep. 2022;4(9):100532. doi:10.1016/j.jhepr.2022.100532
   PubMedGoogle Scholar
• Jia Y, Cui R, Wang C, et al. Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway. Redox Biol. 2020;32:101534. doi:10.1016/j.redox.2020.101534
   PubMed Web of Science ®Google Scholar
• Jung H, Kim MJ, Kim DO, et al. TXNIP maintains the hematopoietic cell pool by switching the function of p53 under oxidative stress. Cell Metab. 2013;18(1):75–85. doi:10.1016/j.cmet.2013.06.002
   PubMed Web of Science ®Google Scholar
• Masutani H. Thioredoxin-Interacting Protein in Cancer and Diabetes. Antioxid Redox Signaling. 2022;36(13–15):1001–1022. doi:10.1089/ars.2021.0038
   PubMed Web of Science ®Google Scholar
• Yoshihara E. TXNIP/TBP-2: a Master Regulator for Glucose Homeostasis. Antioxidants. 2020;9(8):765. doi:10.3390/antiox9080765
   Web of Science ®Google Scholar
• Joshi S, Wang W, Peck AB, Khan SR. Activation of the NLRP3 inflammasome in association with calcium oxalate crystal induced reactive oxygen species in kidneys. J Urol. 2015;193(5):1684–1691. doi:10.1016/j.juro.2014.11.093
   PubMed Web of Science ®Google Scholar
• Schroder K, Zhou R, Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science. 2010;327(5963):296–300. doi:10.1126/science.1184003
   PubMed Web of Science ®Google Scholar
• Kahlenberg JM, Thacker SG, Berthier CC, Cohen CD, Kretzler M, Kaplan MJ. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus. J Immunol. 2011;187(11):6143–6156. doi:10.4049/jimmunol.1101284
   PubMed Web of Science ®Google Scholar
• Deng Y, Han X, Yao Z, et al. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway. Cell Phys Biochem. 2017;42(6):2255–2266. doi:10.1159/000479999
   PubMedGoogle Scholar
• Krock BL, Skuli N, Simon MC. Hypoxia-induced angiogenesis: good and evil. Genes Cancer. 2011;2(12):1117–1133. doi:10.1177/1947601911423654
   PubMedGoogle Scholar
• Luo Z, Tian M, Yang G, et al. Hypoxia signaling in human health and diseases: implications and prospects for therapeutics. Signal Transduction Targeted Therapy. 2022;7(1):218. doi:10.1038/s41392-022-01080-1
   PubMed Web of Science ®Google Scholar
• Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in Cell Death, Inflammation, and Pyroptosis. Ann Rev Immunol. 2020;38(1):567–595. doi:10.1146/annurev-immunol-073119-095439
   PubMedGoogle Scholar
• Eguchi R, Suzuki A, Miyakaze S, Kaji K, Ohta T. Hypoxia induces apoptosis of HUVECs in an in vitro capillary model by activating proapoptotic signal p38 through suppression of ERK1/2. Cell. Signalling. 2007;19(6):1121–1131. doi:10.1016/j.cellsig.2006.12.004
   PubMed Web of Science ®Google Scholar
• Zhang M, Chen Y, Qiu Y, et al. PCSK9 Promotes Hypoxia-Induced EC Pyroptosis by Regulating Smac Mitochondrion-Cytoplasm Translocation in Critical Limb Ischemia. JACC. 2023;8(9):1060–1077. doi:10.1016/j.jacbts.2023.05.016
   Google Scholar
• Koppaka V, Thompson DC, Chen Y, et al. Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application. Pharmacol Rev. 2012;64(3):520–539. doi:10.1124/pr.111.005538
   PubMed Web of Science ®Google Scholar
• Hu JJ, Liu X. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nature Immunol. 2020;21(7):736–745. doi:10.1038/s41590-020-0669-6
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang R, Han X. Disulfiram inhibits inflammation and fibrosis in a rat unilateral ureteral obstruction model by inhibiting gasdermin D cleavage and pyroptosis. Int J Med. 2021;70(5):543–552. doi:10.1007/s00011-021-01457-y
   Google Scholar
• Hu S, Wang L, Xu Y, Li F, Wang T. Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs. Respir Res. 2022;23(1):353. doi:10.1186/s12931-022-02279-0
   PubMed Web of Science ®Google Scholar
• Zhuang L, Luo X, Wu S, et al. Disulfiram alleviates pristane-induced lupus via inhibiting GSDMD-mediated pyroptosis. Cell Death Discovery. 2022;8(1):379. doi:10.1038/s41420-022-01167-2
   PubMed Web of Science ®Google Scholar
• Cai Q, Sun Z, Xu S, et al. Disulfiram ameliorates ischemia/reperfusion-induced acute kidney injury by suppressing the caspase-11-GSDMD pathway. Renal Failure. 2022;44(1):1169–1181. doi:10.1080/0886022x.2022.2098764
   PubMed Web of Science ®Google Scholar
• Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: an Update. Cell Transplantation. 2016;25(5):829–848. doi:10.3727/096368915x689622
   PubMed Web of Science ®Google Scholar
• Lee BH, Park JN, Lee EJ, Moon YW, Wang JH. Therapeutic Efficacy of Spherical Aggregated Human Bone Marrow-Derived Mesenchymal Stem Cells Cultured for Osteochondral Defects of Rabbit Knee Joints. Am j Sports Med. 2018;46(9):2242–2252. doi:10.1177/0363546518780991
   PubMed Web of Science ®Google Scholar
• Kwon SG, Kwon YW, Lee TW, Park GT, Kim JH. Recent advances in stem cell therapeutics and tissue engineering strategies. Biomaterials Res. 2018;22:36. doi:10.1186/s40824-018-0148-4
   PubMedGoogle Scholar
• Wong VW, Sorkin M, Gurtner GC. Enabling stem cell therapies for tissue repair: current and future challenges. Biotechnol. Adv. 2013;31(5):744–751. doi:10.1016/j.biotechadv.2012.11.006
   PubMed Web of Science ®Google Scholar
• Jing H, He X, Zheng J. Exosomes and regenerative medicine: state of the art and perspectives. Translational Res. 2018;196:1–16. doi:10.1016/j.trsl.2018.01.005
   PubMed Web of Science ®Google Scholar
• Sufianov A, Kostin A, Begliarzade S, et al. Exosomal non coding RNAs as a novel target for diabetes mellitus and its complications. Non-Coding RNA Res. 2023;8(2):192–204. doi:10.1016/j.ncrna.2023.02.001
   PubMed Web of Science ®Google Scholar
• Chang W, Wang M, Zhang Y, et al. Roles of long noncoding RNAs and small extracellular vesicle-long noncoding RNAs in type 2 diabetes. Traffic. 2022;23(11):526–537. doi:10.1111/tra.12868
   PubMed Web of Science ®Google Scholar
• Li B, Luan S, Chen J, et al. The MSC-Derived Exosomal lncRNA H19 Promotes Wound Healing in Diabetic Foot Ulcers by Upregulating PTEN via MicroRNA-152-3p. Mol Ther Nucleic Acids. 2020;19:814–826. doi:10.1016/j.omtn.2019.11.034
   PubMedGoogle Scholar
• Glenn JD, Whartenby KA. Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy. World j Stem Cells. 2014;6(5):526–539. doi:10.4252/wjsc.v6.i5.526
   PubMedGoogle Scholar
• Fortier LA, Potter HG, Rickey EJ, et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am Vol. 2010;92(10):1927–1937. doi:10.2106/jbjs.i.01284
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yuan J, Zhou B, et al. The therapeutic efficacy of human adipose tissue-derived mesenchymal stem cells on experimental autoimmune hearing loss in mice. Immunology. 2011;133(1):133–140. doi:10.1111/j.1365-2567.2011.03421.x
   PubMed Web of Science ®Google Scholar
• Li M, Luan F, Zhao Y, et al. Mesenchymal stem cell-conditioned medium accelerates wound healing with fewer scars. Int Wound J. 2017;14(1):64–73. doi:10.1111/iwj.12551
   PubMed Web of Science ®Google Scholar
• Jo H, Brito S, Kwak BM. Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation. Int J Med. 2021;22(5).
   Google Scholar
• Bian D, Wu Y, Song G. The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: a comprehensive review. Jan. 2022;13(1):24. doi:10.1186/s13287-021-02697-9
   Google Scholar
• Hu CH, Tseng YW, Chiou CY, et al. Bone marrow concentrate-induced mesenchymal stem cell conditioned medium facilitates wound healing and prevents hypertrophic scar formation in a rabbit ear model. Stem Cell Res Ther. 2019;10(1):275. doi:10.1186/s13287-019-1383-x
   PubMed Web of Science ®Google Scholar
• Sun B, Guo S, Xu F, et al. Concentrated Hypoxia-Preconditioned Adipose Mesenchymal Stem Cell-Conditioned Medium Improves Wounds Healing in Full-Thickness Skin Defect Model. Int Scholarly Res Notices. 2014;2014:652713. doi:10.1155/2014/652713
   PubMedGoogle Scholar
• Li M, Zhao Y, Hao H, et al. Mesenchymal stem cell-conditioned medium improves the proliferation and migration of keratinocytes in a diabetes-like microenvironment. Int j Lower Extremity Wounds. 2015;14(1):73–86. doi:10.1177/1534734615569053
   PubMed Web of Science ®Google Scholar
• Laksmitawati DR, Noor SU, Sumiyati Y, Hartanto A, Widowati W, Pratami DK. The effect of mesenchymal stem cell-conditioned medium gel on burn wound healing in rat. Vet World. 2022;15(4):841–847. doi:10.14202/vetworld.2022.841-847
   PubMed Web of Science ®Google Scholar
• Karnam K, Sedmaki K, Sharma P, et al. HDAC6 inhibitor accelerates wound healing by inhibiting tubulin mediated IL-1β secretion in diabetic mice. Biochim Biophys Acta Mol Basis Dis. 2020;1866(11):165903. doi:10.1016/j.bbadis.2020.165903
   PubMed Web of Science ®Google Scholar
• Wang Y, Wan L, Zhang Z, Li J, Qu M, Zhou Q. Topical calcitriol application promotes diabetic corneal wound healing and reinnervation through inhibiting NLRP3 inflammasome activation. Exp. Eye Res. 2021;209:108668. doi:10.1016/j.exer.2021.108668
   PubMed Web of Science ®Google Scholar
• Li X, Wang T, Tao Y, Wang X, Li L, Liu J. MF-094, a potent and selective USP30 inhibitor, accelerates diabetic wound healing by inhibiting the NLRP3 inflammasome. Exp. Cell. Res. 2022;410(2):112967. doi:10.1016/j.yexcr.2021.112967
   PubMed Web of Science ®Google Scholar
• Tombulturk FK, Todurga-Seven ZG, Huseyinbas O, Ozyazgan S, Ulutin T, Kanigur-Sultuybek G. Topical application of metformin accelerates cutaneous wound healing in streptozotocin-induced diabetic rats. Jan. 2022;49(1):73–83. doi:10.1007/s11033-021-06843-7
   Google Scholar
• Zhao Y, Wang Q, Yan S, et al. Bletilla striata Polysaccharide Promotes Diabetic Wound Healing Through Inhibition of the NLRP3 Inflammasome. Front Pharmacol. 2021;12:659215. doi:10.3389/fphar.2021.659215
   PubMed Web of Science ®Google Scholar
• Wang T, Zhao J, Zhang J, et al. Heparan sulfate inhibits inflammation and improves wound healing by downregulating the NLR family pyrin domain containing 3 (NLRP3) inflammasome in diabetic rats. J Diabetes. 2018;10(7):556–563. doi:10.1111/1753-0407.12630
   PubMed Web of Science ®Google Scholar
• Song J, Zeng J, Zheng S, et al. Sanguisorba officinalis L. promotes diabetic wound healing in rats through inflammation response mediated by macrophage. Phytotherapy Res. 2023;37(9):4265.
   PubMed Web of Science ®Google Scholar
• Eo H, Lee HJ, Lim Y. Ameliorative effect of dietary genistein on diabetes induced hyper-inflammation and oxidative stress during early stage of wound healing in alloxan induced diabetic mice. Biochem Biophysical Res Commun. 2016;478(3):1021.
   PubMed Web of Science ®Google Scholar
• Wang Y, Jing L, Lei X, et al. Umbilical cord mesenchymal stem cell-derived apoptotic extracellular vesicles ameliorate cutaneous wound healing in type 2 diabetic mice via macrophage pyroptosis inhibition. Analytical Cell Pathol. 2022;2022.
   Google Scholar
• Dai J, Jiang C, Chen H, Chai Y. Rapamycin Attenuates High Glucose-Induced Inflammation Through Modulation of mTOR/NF-κB Pathways in Macrophages. Front Pharmacol. 2019;10:1292. doi:10.3389/fphar.2019.01292
   PubMed Web of Science ®Google Scholar
• Sun X, Wang X, Zhao Z, Chen J, Li C, Zhao G. Paeoniflorin inhibited nod-like receptor protein-3 inflammasome and NF-κB-mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR2. Drug Dev Res 2021;82(3):404–411. doi:10.1002/ddr.21763
   PubMed Web of Science ®Google Scholar
• Mi J, Xie C, Zeng L, et al. Bacillus subtilis WB800N alleviates diabetic wounds in mice by regulating gut microbiota homeostasis and TLR2. J Appl Microbiol. 2022;133(2):436–447. doi:10.1111/jam.15547
   PubMed Web of Science ®Google Scholar
• Bassett SA, Barnett MP. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease. Nutrients. 2014;6(10):4273–4301. doi:10.3390/nu6104273
   PubMed Web of Science ®Google Scholar
• Xu J, Zhao X, Jiang X, et al. Tubastatin A Improves Post-Resuscitation Myocardial Dysfunction by Inhibiting NLRP3-Mediated Pyroptosis Through Enhancing Transcription Factor EB Signaling. J Am Heart Assoc. 2022;11(7):e024205. doi:10.1161/jaha.121.024205
   PubMed Web of Science ®Google Scholar
• Mirza RE, Fang MM, Ennis WJ, Koh TJ. Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes. 2013;62(7):2579–2587. doi:10.2337/db12-1450
   PubMed Web of Science ®Google Scholar
• Udumula MP, Mangali S, Kalra J, et al. High fructose and streptozotocin induced diabetic impairments are mitigated by Indirubin-3-hydrazone via downregulation of PKR pathway in Wistar rats. Sci Rep. 2021;11(1):12924. doi:10.1038/s41598-021-92345-2
   PubMed Web of Science ®Google Scholar
• Nakamura T, Furuhashi M, Li P, et al. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell. 2010;140(3):338–348. doi:10.1016/j.cell.2010.01.001
   PubMed Web of Science ®Google Scholar
• Nakamura T, Arduini A, Baccaro B, Furuhashi M, Hotamisligil GS. Small-molecule inhibitors of PKR improve glucose homeostasis in obese diabetic mice. Diabetes. 2014;63(2):526–534. doi:10.2337/db13-1019
   PubMed Web of Science ®Google Scholar
• Carvalho-Filho MA, Carvalho BM, Oliveira AG, et al. Double-stranded RNA-activated protein kinase is a key modulator of insulin sensitivity in physiological conditions and in obesity in mice. Endocrinology. 2012;153(11):5261–5274. doi:10.1210/en.2012-1400
   PubMed Web of Science ®Google Scholar
• Mangali S, Bhat A, Jadhav K, et al. Upregulation of PKR pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in Wistar rats and in vitro in cultured cardiomyocytes. Biochem Pharmacol 2020;177:113948. doi:10.1016/j.bcp.2020.113948
   PubMed Web of Science ®Google Scholar
• Yim HC, Wang D, Yu L, et al. The kinase activity of PKR represses inflammasome activity. Cell Res 2016;26(3):367–379. doi:10.1038/cr.2016.11
   PubMed Web of Science ®Google Scholar
• Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr.Opin Pharmacol 2010;10(4):482–496. doi:10.1016/j.coph.2010.04.001
   PubMed Web of Science ®Google Scholar
• Grammatiki M, Rapti E, Karras S, Ajjan RA, Kotsa K. Vitamin D and diabetes mellitus: causal or casual association? Jun. 2017;18(2):227–241. doi:10.1007/s11154-016-9403-y
   Google Scholar
• Maddaloni E, Cavallari I, Napoli N, Conte C. Vitamin D and Diabetes Mellitus. Front Hormone Res. 2018;50:161–176. doi:10.1159/000486083
   PubMed Web of Science ®Google Scholar
• White JH. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect Immun. 2008;76(9):3837–3843. doi:10.1128/iai.00353-08
   PubMed Web of Science ®Google Scholar
• Reins RY, Hanlon SD, Magadi S, McDermott AM. Effects of Topically Applied Vitamin D during Corneal Wound Healing. PLoS One. 2016;11(4):e0152889. doi:10.1371/journal.pone.0152889
   PubMed Web of Science ®Google Scholar
• Lu X, Vick S, Chen Z, Chen J, Watsky MA. Effects of Vitamin D Receptor Knockout and Vitamin D Deficiency on Corneal Epithelial Wound Healing and Nerve Density in Diabetic Mice. Diabetes. 2020;69(5):1042–1051. doi:10.2337/db19-1051
   PubMed Web of Science ®Google Scholar
• Lv D, Cao X, Zhong L, et al. Targeting phenylpyruvate restrains excessive NLRP3 inflammasome activation and pathological inflammation in diabetic wound healing. Cell Rep Med. 2023;4(8):101129. doi:10.1016/j.xcrm.2023.101129
   PubMedGoogle Scholar
• Huang W, Jiao J, Liu J, et al. MFG-E8 accelerates wound healing in diabetes by regulating ”NLRP3 inflammasome-neutrophil extracellular traps” axis. Cell Death Discovery. 2020;6(1):84. doi:10.1038/s41420-020-00318-7
   PubMed Web of Science ®Google Scholar
• Bian F, Xiao Y, Zaheer M, et al. Inhibition of NLRP3 Inflammasome Pathway by Butyrate Improves Corneal Wound Healing in Corneal Alkali Burn. Int J Mol Sci. 2017;18(3):562. doi:10.3390/ijms18030562
   PubMed Web of Science ®Google Scholar
• Xiao M, Li L, Li C, Liu L, Yu Y, Ma L. 3,4-Methylenedioxy-β-Nitrostyrene Ameliorates Experimental Burn Wound Progression by Inhibiting the NLRP3 Inflammasome Activation. Plastic Reconstructive Surg. 2016;137(3):566e–575e. doi:10.1097/01.prs.0000479972.06934.83
   PubMed Web of Science ®Google Scholar
• Chiu HW, Chen CH, Chang JN, Chen CH, Hsu YH. Far-infrared promotes burn wound healing by suppressing NLRP3 inflammasome caused by enhanced autophagy. J Mol Med. 2016;94(7):809–819. doi:10.1007/s00109-016-1389-0
   PubMed Web of Science ®Google Scholar
• Li M, Hou Q, Zhong L, Zhao Y, Fu X. Macrophage Related Chronic Inflammation in Non-Healing Wounds. Front Immunol. 2021;12:681710. doi:10.3389/fimmu.2021.681710
   PubMed Web of Science ®Google Scholar
• Ochoa-Gonzalez F, Cervantes-Villagrana AR, Fernandez-Ruiz JC, et al. Metformin Induces Cell Cycle Arrest, Reduced Proliferation, Wound Healing Impairment In Vivo and Is Associated to Clinical Outcomes in Diabetic Foot Ulcer Patients. PLoS One. 2016;11(3):e0150900. doi:10.1371/journal.pone.0150900
   PubMed Web of Science ®Google Scholar
• Han X, Tao Y, Deng Y, Yu J, Sun Y, Jiang G. Metformin accelerates wound healing in type 2 diabetic db/db mice. Mol Med Rep. 2017;16(6):8691–8698. doi:10.3892/mmr.2017.7707
   PubMed Web of Science ®Google Scholar
• Zhao P, Sui BD, Liu N, et al. Anti-aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application. Aging Cell. 2017;16(5):1083–1093. doi:10.1111/acel.12635
   PubMed Web of Science ®Google Scholar
• Yang F, Qin Y, Wang Y, et al. Metformin Inhibits the NLRP3 Inflammasome via AMPK/mTOR-dependent Effects in Diabetic Cardiomyopathy. Int J Bio Sci. 2019;15(5):1010–1019. doi:10.7150/ijbs.29680
   Google Scholar
• Zheng Z, Bian Y, Zhang Y, Ren G, Li G. Metformin activates AMPK/SIRT1/NF-κB pathway and induces mitochondrial dysfunction to drive caspase3/GSDME-mediated cancer cell pyroptosis. Cell Cycle. 2020;19(10):1089–1104. doi:10.1080/15384101.2020.1743911
   PubMed Web of Science ®Google Scholar
• Zhang J, Huang L, Shi X, et al. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway. Aging. 2020;12(23):24270–24287. doi:10.18632/aging.202143
   PubMedGoogle Scholar
• Zhou X, Wang Q, Nie L, et al. Metformin ameliorates the NLPP3 inflammasome mediated pyroptosis by inhibiting the expression of NEK7 in diabetic periodontitis. Arch Oral Biol. 2020;116:104763. doi:10.1016/j.archoralbio.2020.104763
   PubMed Web of Science ®Google Scholar
• Yuan Y, Fan X. Metformin Protects against Spinal Cord Injury and Cell Pyroptosis via AMPK/NLRP3. Inflammasome Pathway. 2022;2022:3634908. doi:10.1155/2022/3634908
   Google Scholar
• Qing L, Fu J, Wu P, Zhou Z, Yu F, Tang J. Metformin induces the M2 macrophage polarization to accelerate the wound healing via regulating AMPK/mTOR/NLRP3 inflammasome singling pathway. Am J Transl Res. 2019;11(2):655–668.
   PubMed Web of Science ®Google Scholar
• He X, Wang X, Fang J, et al. Bletilla striata: medicinal uses, phytochemistry and pharmacological activities. J Ethnopharmacol. 2017;195:20–38. doi:10.1016/j.jep.2016.11.026
   PubMed Web of Science ®Google Scholar
• Ji X, Yin M, Nie H. A Review of Isolation, Chemical Properties, and Bioactivities of Polysaccharides from Bletilla striata. BioMed Research International. 2020;2020:5391379. doi:10.1155/2020/5391379
   PubMed Web of Science ®Google Scholar
• Yue L, Wang W, Wang Y, et al. Bletilla striata polysaccharide inhibits angiotensin II-induced ROS and inflammation via NOX4 and TLR2 pathways. Int J Biol Macromol. 2016;89:376–388. doi:10.1016/j.ijbiomac.2016.05.002
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhao Y, Zhang M, et al. Structural characterization and antioxidant activity of a new polysaccharide from Bletilla striata fibrous roots. Carbohydr Polym. 2020;227:115362. doi:10.1016/j.carbpol.2019.115362
   PubMed Web of Science ®Google Scholar
• Zhang C, He Y, Chen Z, Shi J, Qu Y. Effect of Polysaccharides from Bletilla striata on the Healing of Dermal Wounds in Mice. EvidComplementary Alternative Med. 2019;2019:9212314. doi:10.1155/2019/9212314
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lv T, Li M, et al. Anti-aging effect of polysaccharide from Bletilla striata on nematode Caenorhabditis elegans. Pharmacogn Mag. 2015;11(43):449–454. doi:10.4103/0973-1296.160447
   PubMed Web of Science ®Google Scholar
• Chen Z, Cheng L, He Y, Wei X. Extraction, characterization, utilization as wound dressing and drug delivery of Bletilla striata polysaccharide: a review. Int J Biol Macromol. 2018;120(Pt B):2076–2085. doi:10.1016/j.ijbiomac.2018.09.028
   PubMedGoogle Scholar
• Ding L, Shan X, Zhao X, et al. Spongy bilayer dressing composed of chitosan-Ag nanoparticles and chitosan-Bletilla striata polysaccharide for wound healing applications. Carbohydr Polym. 2017;10(157):1538–1547. doi:10.1016/j.carbpol.2016.11.040
   Google Scholar
• Luo Y, Diao H, Xia S, Dong L, Chen J, Zhang J. A physiologically active polysaccharide hydrogel promotes wound healing. J Biomed Mater Res Part A. 2010;94(1):193–204. doi:10.1002/jbm.a.32711
   PubMed Web of Science ®Google Scholar
• Wu XG, Xin M, Chen H, Yang LN, Jiang HR. Novel mucoadhesive polysaccharide isolated from Bletilla striata improves the intraocular penetration and efficacy of levofloxacin in the topical treatment of experimental bacterial keratitis. J Pharm Pharmacol. 2010;62(9):1152–1157. doi:10.1111/j.2042-7158.2010.01137.x
   PubMed Web of Science ®Google Scholar
• Yu L, Nie X, Pan H, Ling S, Zhang D, Bian K. Diabetes mellitus ulcers treatment with Bletilla striata polysaccharide]. China J Chinese Materia Medica. 2011;36(11):1487–1491.
   Google Scholar
• Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regeneratio. 2009;17(2):153–162. doi:10.1111/j.1524-475X.2009.00466.x
   PubMed Web of Science ®Google Scholar
• Bosman FT, Stamenkovic I. Functional structure and composition of the extracellular matrix. J Pathol. 2003;200(4):423–428. doi:10.1002/path.1437
   PubMed Web of Science ®Google Scholar
• Chang Z, Meyer K, Rapraeger AC, Friedl A. Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ. FASEB j. 2000;14(1):137–144. doi:10.1096/fasebj.14.1.137
   PubMed Web of Science ®Google Scholar
• Bame KJ. Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans. Glycobiology. 2001;11(6):91r–98r. doi:10.1093/glycob/11.6.91r
   PubMed Web of Science ®Google Scholar
• Menini S, Iacobini C, Vitale M. The Inflammasome in Chronic Complications of Diabetes and Related Metabolic Disorders. Cells. 2020;9(8). doi:10.3390/cells9081812
   PubMed Web of Science ®Google Scholar
• Gawron-Gzella A, Witkowska-Banaszczak E, Bylka W, Dudek-Makuch M, Odwrot A, Skrodzka N. Chemical Composition, Antioxidant and Antimicrobial Activities of Sanguisorba officinalis L. Extracts. Pharm Chem J. 2016;50(4):244–249. doi:10.1007/s11094-016-1431-0
   PubMed Web of Science ®Google Scholar
• Cheng D-L, Cao X-P. Pomolic acid derivatives from the root of Sanguisorba officinalis. Phytochemistry. 1992;31(4):1317–1320. doi:10.1016/0031-9422(92)80499-5
   Web of Science ®Google Scholar
• Chen JF, Tan L, Ju F, et al. Phenolic glycosides from Sanguisorba officinalis and their anti-inflammatory effects. Nat Product Res. 2022;36(8):2097–2104. doi:10.1080/14786419.2020.1849202
   PubMed Web of Science ®Google Scholar
• Yasueda A, Kayama H, Murohashi M, et al. Sanguisorba officinalis L. derived from herbal medicine prevents intestinal inflammation by inducing autophagy in macrophages. Sci Rep. 2020;10(1):9972. doi:10.1038/s41598-020-65306-4
   PubMed Web of Science ®Google Scholar
• Zhou P, Li J, Chen Q, et al. A Comprehensive Review of Genus Sanguisorba: traditional Uses, Chemical Constituents and Medical Applications. Front Pharmacol. 2021;12:750165. doi:10.3389/fphar.2021.750165
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen J, Cen Y. Burn wound healing potential of a polysaccharide from Sanguisorba officinalis L. in mice. Int J Biol Macromol. 2018;112:862–867. doi:10.1016/j.ijbiomac.2018.01.214
   PubMed Web of Science ®Google Scholar
• Wang TT. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis. 1996;17(2):271.
   PubMed Web of Science ®Google Scholar
• Park E, Lee Sm Fau - Jung I-K, Jung Ik Fau - Lim Y, Lim Y, Fau - Kim J-H, Kim JH. Effects of genistein on early-stage cutaneous wound healing. Biochem Biophysical Res Commun. 2011;410(3):514.,
   PubMed Web of Science ®Google Scholar
• Hirota SA, Ng J, Fau - lueng A, et al. NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflammatory Bowel Dis. 2011;17(6):1359.
   PubMed Web of Science ®Google Scholar
• Zaki MH. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity. 2010;32(3):379.
   PubMed Web of Science ®Google Scholar
• Nagamura-Inoue T, He H. Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. World j Stem Cells. 2014;6(2):195–202. doi:10.4252/wjsc.v6.i2.195
   PubMedGoogle Scholar
• Zhang B, Wang M, Gong A, et al. HucMSC-Exosome Mediated-Wnt4 Signaling Is Required for Cutaneous Wound Healing. Stem Cells. 2015;33(7):2158.
   PubMed Web of Science ®Google Scholar
• Panepucci RA, et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells. 2004;22(7):1263.
   PubMed Web of Science ®Google Scholar
• Chen W, Liu J. Umbilical cord and bone marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in rat cranial defects. Biomaterials. 2013;34(38):9917.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yu G, Cai M, et al. Bibliometric analysis of global scientific activity on umbilical cord mesenchymal stem cells: a swiftly expanding and shifting focus. Stem Cell Res Therapy. 2018;9(1):1.
   PubMedGoogle Scholar
• Rendra E, Riabov V, Mossel DM, Sevastyanova T, Harmsen MC, Kzhyshkowska J. Reactive oxygen species (ROS) in macrophage activation and function in diabetes. Immunobiology. 2019;224(2):242.
   PubMed Web of Science ®Google Scholar
• Banerjee M, Vats P. Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus. Redox Bbiol. 2014;2:170.
   PubMed Web of Science ®Google Scholar
• Bandeira Sde M, Guedes Gda S, da Fonseca LJS, et al. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxidative Med Cell Longevity. 2012;2012. doi:10.1155/2012/819310
   PubMed Web of Science ®Google Scholar
• Bacanlı M, Anlar HG, Aydın S, et al. d-limonene ameliorates diabetes and its complications in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2017;110:434.
   PubMed Web of Science ®Google Scholar
• Jamal Gilani S, Bin-Jumah M N, Al-Abbasi FA, et al. Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes. Saudi J Biol Sci. 2021;28(12):6963.
   PubMed Web of Science ®Google Scholar
• Iskender H, Dokumacioglu E, Sen TM, Ince I, Kanbay Y, Saral S. The effect of hesperidin and quercetin on oxidative stress, NF-κB and SIRT1 levels in a STZ-induced experimental diabetes model. Biomed icine Pharmacother. 2017;90:500.
   PubMed Web of Science ®Google Scholar
• Abais JM, Xia M, Fau - Zhang Y, et al. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxidants Redox Signaling. 2015;22(13):1111.
   PubMed Web of Science ®Google Scholar
• Jia X, Cao B, An Y, Zhang X, Wang C. Rapamycin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting IL-1β and IL-18 production. Int Immunopharmacol. 2019;67:211.
   PubMed Web of Science ®Google Scholar
• Xiao M, Li L, Fau - Hu Q, et al. Rapamycin reduces burn wound progression by enhancing autophagy in deep second-degree burn in rats. Regeneration. 2013;21(6):852.
   Web of Science ®Google Scholar
• Mills RE, Taylor KR, Podshivalova K, McKay DB, Jameson JM. Defects in Skin γδ T Cell Function Contribute to Delayed Wound Repair in Rapamycin-Treated Mice1. J Immunol. 2008;181(6):3974–3983. doi:10.4049/jimmunol.181.6.3974
   PubMed Web of Science ®Google Scholar
• Jung CH, Jun CB, Ro SH, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. ?mol Biol Cell. 2009;20(7):1992–2003. doi:10.1091/mbc.e08-12-1249
   Web of Science ®Google Scholar
• Dai J, Zhang X, Li L, Chen H, Chai Y. Autophagy Inhibition Contributes to ROS-Producing NLRP3-Dependent Inflammasome Activation and Cytokine Secretion in High Glucose-Induced Macrophages. Cell Phys Biochem. 2017;43(1):247–256. doi:10.1159/000480367
   PubMedGoogle Scholar
• Liu YC, Gao XX, Chen L, You XQ. Rapamycin suppresses Aβ(25-35)- or LPS-induced neuronal inflammation via modulation of NF-κB signaling. Neuroscience. 2017;355:188–199. doi:10.1016/j.neuroscience.2017.05.005
   PubMed Web of Science ®Google Scholar
• Wen J, Xu B, Sun Y, et al. Paeoniflorin protects against intestinal ischemia/reperfusion by activating LKB1/AMPK and promoting autophagy. Pharmacol Res. 2019;146:104308. doi:10.1016/j.phrs.2019.104308
   PubMed Web of Science ®Google Scholar
• Yin N, Gao Q, Tao W, et al. Paeoniflorin relieves LPS-induced inflammatory pain in mice by inhibiting NLRP3 inflammasome activation via transient receptor potential vanilloid 1. Journal of Leukocyte Biology. 2020;108(1):229–241. doi:10.1002/jlb.3ma0220-355r
   PubMed Web of Science ®Google Scholar
• Sun X, Wang X, Zhao Z, Chen J, Li C, Zhao G. Paeoniflorin accelerates foot wound healing in diabetic rats though activating the Nrf2 pathway. Acta Histochem. 2020;122(8):151649. doi:10.1016/j.acthis.2020.151649
   PubMed Web of Science ®Google Scholar
• Citro A, Valle A. CXCR1/2 inhibition blocks and reverses type 1 diabetes in mice. Diabetes. 2015;64(4):1329–1340. doi:10.2337/db14-0443
   PubMed Web of Science ®Google Scholar
• Zou XY, Zhang M, Tu WJ, et al. Bacillus subtilis inhibits intestinal inflammation and oxidative stress by regulating gut flora and related metabolites in laying hens. Animal. 2022;16(3):100474. doi:10.1016/j.animal.2022.100474
   PubMed Web of Science ®Google Scholar
• Liu Y, Ding S, Dietrich R, Märtlbauer E, Zhu K. A Biosurfactant-Inspired Heptapeptide with Improved Specificity to Kill MRSA. Angewandte Chemie. 2017;56(6):1486–1490. doi:10.1002/anie.201609277
   Google Scholar
• Ansari A, Zohra RR, Tarar OM, Qader SAU, Aman A. Screening, purification and characterization of thermostable, protease resistant Bacteriocin active against methicillin resistant Staphylococcus aureus (MRSA). BMC Microbiol 2018;18(1):192. doi:10.1186/s12866-018-1337-y
   PubMedGoogle Scholar
• Tan F, Limbu SM, Qian Y, Qiao F, Du ZY, Zhang M. The Responses of Germ-Free Zebrafish (Danio rerio) to Varying Bacterial Concentrations, Colonization Time Points, and Exposure Duration. Front Microbiol. 2019;10:2156. doi:10.3389/fmicb.2019.02156
   PubMed Web of Science ®Google Scholar
• Huon JF, Montassier E, Leroy AG, Grégoire M. Phages versus Antibiotics To Treat Infected Diabetic Wounds in a Mouse Model: a Microbiological and Microbiotic Evaluation. mSystems. 2020;5(6). doi:10.1128/mSystems.00542-20
   PubMed Web of Science ®Google Scholar
• Bortoluzzi C, Serpa Vieira B, de Paula Dorigam JC, et al. Bacillus subtilis DSM 32315 Supplementation Attenuates the Effects of Clostridium perfringens Challenge on the Growth Performance and Intestinal Microbiota of Broiler Chickens. Microorganisms. 2019;7(3):71. doi:10.3390/microorganisms7030071
   PubMed Web of Science ®Google Scholar
• Li Y, Xu Q, Huang Z, et al. Effect of Bacillus subtilis CGMCC 1.1086 on the growth performance and intestinal microbiota of broilers. J Appl Microbiol. 2016;120(1):195–204. doi:10.1111/jam.12972
   PubMed Web of Science ®Google Scholar
• Shofler D, Rai V, Mansager S, Cramer K, Agrawal DK. Impact of resolvin mediators in the immunopathology of diabetes and wound healing. Jun. 2021;17(6):681–690. doi:10.1080/1744666x.2021.1912598
   Google Scholar
• Koch KN, Hartung ML, Urban S, et al. Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma. J Clin Invest. 2015;125(8):3297–3302. doi:10.1172/jci79337
   PubMed Web of Science ®Google Scholar
• He X, Mekasha S, Mavrogiorgos N, Fitzgerald KA, Lien E, Ingalls RR. Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. J Immunol. 2010;184(10):5743–5754. doi:10.4049/jimmunol.0903937
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Mueller JL, Vitari AC, et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol. 2009;187(1):61–70. doi:10.1083/jcb.200903124
   PubMed Web of Science ®Google Scholar
• He Y, Chang Y, Peng Y, et al. Glibenclamide Directly Prevents Neuroinflammation by Targeting SUR1-TRPM4-Mediated NLRP3 Inflammasome Activation In Microglia. Mol Neurobiol. 2022;59(10):6590–6607. doi:10.1007/s12035-022-02998-x
   PubMed Web of Science ®Google Scholar
• Arita Y, Yoshinaga Y. Glyburide inhibits the bone resorption induced by traumatic occlusion in rats. Jun. 2020;55(3):464–471. doi:10.1111/jre.12731
   Google Scholar
• Lin YW, Liu PS, Pook KA, Wei LN. Glyburide and retinoic acid synergize to promote wound healing by anti-inflammation and RIP140 degradation. Sci Rep. 2018;8(1):834. doi:10.1038/s41598-017-18785-x
   PubMedGoogle Scholar
• Franchi L, Eigenbrod T, Muñoz-Planillo R, Nuñez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009;10(3):241–247. doi:10.1038/ni.1703
   PubMed Web of Science ®Google Scholar
• Chiazza F, Couturier-Maillard A, Benetti E, et al. Targeting the NLRP3 Inflammasome to Reduce Diet-Induced Metabolic Abnormalities in Mice. Mol Med. 2016;21(1):1025–1037. doi:10.2119/molmed.2015.00104
   PubMedGoogle Scholar
• Xu C, Zhang Y, Sutrisno L, Yang L, Chen R, Sung KLP. Bay11-7082 facilitates wound healing by antagonizing mechanical injury- and TNF-α-induced expression of MMPs in posterior cruciate ligament. Connective Tissue Res. 2019;60(4):311–322. doi:10.1080/03008207.2018.1512978
   PubMed Web of Science ®Google Scholar
• Wen H, Miao EA, Ting JP. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity. 2013;39(3):432–441. doi:10.1016/j.immuni.2013.08.037
   PubMed Web of Science ®Google Scholar
• Shimada K, Crother TR, Karlin J, et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity. 2012;36(3):401–414. doi:10.1016/j.immuni.2012.01.009
   PubMed Web of Science ®Google Scholar
• Wu D, Chen Y, Sun Y, et al. Target of MCC950 in Inhibition of NLRP3 Inflammasome Activation: a Literature Review. Inflammation. 2020;43(1):17–23. doi:10.1007/s10753-019-01098-8
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhu X, Li L, et al. A small molecule inhibitor MCC950 ameliorates kidney injury in diabetic nephropathy by inhibiting NLRP3 inflammasome activation. Diabetes, metabolic syndrome and obesity: targets and therapy. Diabetes Metabolic Syndrome Obesity. 2019;12:1297–1309. doi:10.2147/dmso.s199802
   PubMed Web of Science ®Google Scholar
• Zhai Y, Meng X, Ye T, Xie W, Sun G, Sun X. Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db/db Mice. Molecules. 2018;23(3):522. doi:10.3390/molecules23030522
   PubMed Web of Science ®Google Scholar
• Zeng W, Wu D, Sun Y, et al. The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages. Sci Rep. 2021;11(1):19305. doi:10.1038/s41598-021-98437-3
   PubMed Web of Science ®Google Scholar
• Coll RC, Robertson AA, Chae JJ, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Mar. 2015;21(3):248–255. doi:10.1038/nm.3806
   Google Scholar